Uniformity of weight for unit dosage (n=3). All formulations are designed to contain 10 mg NIF. The percentage listed under formulation column details the w/w % of NIF in PVP of the in-situ capsule FD formulations. Expected weight of formulation is comprised of the average weight of empty capsule (90 mg ± 0.2%), the target weight of NIF (10 ± 0.5 mg) and the target weight of PVP depending on the NIF:PVP ratio used. Figure 2S Comparing the concentration of nifedipine (A) after 5 min of dissolution (B) after 60 min of dissolution and (C) after 5 days of equilibrium (thermodynamic solubility). The dissolution medium is 0.1M HCL, with the exception to NIF as received* in (A) & (B) Only when testing nifedipine as received*, the dissolution medium also contained PVP at concentrations equal to those resulted by the full dissolution of PVP from equivalent FD formulations in 900 mL 0.1M HCl (e.g. NIF as received* with an xaxis (composition w/w % NIF in PVP) of 50%, indicates that the dissolution medium for this particular test contained a pre-dissolved 10 mg of PVP). Error bars represent standard error (n=3). Circled data point in (C) was considered an outlier caused by an artefact, and therefore was not included in linear regression analysis. 
Standard error of intercept (!") Regression analysis 1.57
LOD of crystalline NIF in w/w % = 3.3 × ! ! 5.15%
LOQ of crystalline NIF in enthalpy = 10 × ! ! 15.62% Figure 4S ESEM of A) freeze-dried 100% w/w NIF, B) freeze-dried 100% w/w PVP, C) & D) freezedried 50% w/w NIF in PVP and freeze dried 10% w/w NIF in PVP respectively.
